Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Novaccess Global Inc XSNX

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.


OTCQB:XSNX - Post by User

Comment by Sonali1997on Jul 11, 2018 12:43pm
100 Views
Post# 28300461

RE:RE:NEW NEWS NEWS

RE:RE:NEW NEWS NEWS[ I like this company ...new innovation..contracts on hand and making money too.... ----------------------------- ----------------------'zxxxxxxx------------------------------- ----------------------------------'zzzzzzx---------------------- ........................................... XsunX Marketing Continues to See Sales Results 2018-07-10 08:30 ET - News Release Company Ends June With Two More Commercial Solar Projects Awarded ALISO VIEJO, CA, July 10, 2018 (GLOBE NEWSWIRE) -- XsunX, Inc. ( OTC: XSNX ), a leading solar and energy saving technologies provider, announced today that it continues to see its large pool of pending sales proposals close resulting in the generation of two newly awarded projects in June. Our deal flow is continuing to outpace 2017 and, as a bonus, we are seeing some of the larger projects we bid in 2017 start to develop interest in moving forward which is great news, stated Tom Djokovich, CEO of XsunX, Inc. With June ending strong, our 3rd quarter totals broke the $1,000,000 mark in new project awards which continues to help put us on track for a better year than 2017. quote=teheran10].....Like we have already said before, BUY and forget about this stock for 2-3 years, soon enough this stock is going to trade in $.50-$1 range.
I believe this is a great opportunity to invest a few spare dollars here.
$1,000 can make you $300K in a few years[/quote]

<< Previous
Bullboard Posts
Next >>